COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper
Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, hig...
Saved in:
| Published in: | Basic and clinical neuroscience Vol. 11; no. 2; pp. 133 - 150 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Iran
Negah Scientific Publisher
01.03.2020
Iranian Neuroscience Society Iran University of Medical Sciences |
| Subjects: | |
| ISSN: | 2008-126X, 2228-7442 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD). |
|---|---|
| AbstractList | Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD). Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD). Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD). |
| Author | Dom, Geert Tabarsi, Payam Tolomeo, Serenella Nematollahi, Pardis Ekhtiari, Hamed Clausen, Thomas Farhoudian, Ali Hash-Emian, Seyed Mohammadreza Radfar, Seyed Ramin Razaghi, Emran Mohammad Schütz, Christian G Gerra, Gilberto Sadeghi, Mandana Mokri, Azarakhsh Galea-Singer, Susanna Baldacchino, Alexander Carrà, Giuseppe Kouimtsidis, Christos Clark, Nicolas Demasi, Maryanne |
| Author_xml | – sequence: 1 givenname: Ali orcidid: 0000-0002-8784-522X surname: Farhoudian fullname: Farhoudian, Ali organization: Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran – sequence: 2 givenname: Alexander orcidid: 0000-0002-5388-7376 surname: Baldacchino fullname: Baldacchino, Alexander organization: Division of Population and Behavioral Sciences, St Andrews University Medical School, University of St Andrews, UK – sequence: 3 givenname: Nicolas orcidid: 0000-0001-8697-6183 surname: Clark fullname: Clark, Nicolas organization: Royal Melbourne Hospital, Victoria, Melbourne, Australia – sequence: 4 givenname: Gilberto orcidid: 0000-0002-4987-6818 surname: Gerra fullname: Gerra, Gilberto organization: Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria – sequence: 5 givenname: Hamed orcidid: 0000-0001-6902-8798 surname: Ekhtiari fullname: Ekhtiari, Hamed organization: Laureate Institute for Brain Research, Tulsa, Oklahoma, USA – sequence: 6 givenname: Geert orcidid: 0000-0001-6492-0429 surname: Dom fullname: Dom, Geert organization: Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium – sequence: 7 givenname: Azarakhsh orcidid: 0000-0002-3303-558X surname: Mokri fullname: Mokri, Azarakhsh organization: Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran – sequence: 8 givenname: Mandana orcidid: 0000-0003-4871-2552 surname: Sadeghi fullname: Sadeghi, Mandana organization: Aftab Mehrvarzi Substance Abuse Treatment Center, Tehran, Iran – sequence: 9 givenname: Pardis orcidid: 0000-0002-7668-4280 surname: Nematollahi fullname: Nematollahi, Pardis organization: Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran – sequence: 10 givenname: Maryanne orcidid: 0000-0002-7234-3710 surname: Demasi fullname: Demasi, Maryanne organization: North Richmond Community Health, Victoria, Melbourne, Australia – sequence: 11 givenname: Christian G orcidid: 0000-0002-5445-8290 surname: Schütz fullname: Schütz, Christian G organization: Department of Psychiatry, University of British Columbia, Vancouver BC, Canada – sequence: 12 givenname: Seyed Mohammadreza orcidid: 0000-0002-0876-6559 surname: Hash-Emian fullname: Hash-Emian, Seyed Mohammadreza organization: Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 13 givenname: Payam orcidid: 0000-0002-8932-5420 surname: Tabarsi fullname: Tabarsi, Payam organization: Clinical Tuberculosis and Epidemiology Research Center, National Research Institute for Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 14 givenname: Susanna orcidid: 0000-0002-4175-0137 surname: Galea-Singer fullname: Galea-Singer, Susanna organization: Institute for Innovation and Improvement, IWaitematâ DHB, Centre for Addictions Research, University of Auckland, Auckland, New Zealand – sequence: 15 givenname: Giuseppe orcidid: 0000-0002-6877-6169 surname: Carrà fullname: Carrà, Giuseppe organization: Department of Medicine and Surgery, Section of Psychiatry, University of Milan Bicocca, Milan, Italy – sequence: 16 givenname: Thomas orcidid: 0000-0002-2421-4201 surname: Clausen fullname: Clausen, Thomas organization: Norwegian Centre for Addiction Research (SERAF); University of Oslo, Oslo, Norway – sequence: 17 givenname: Christos orcidid: 0000-0001-9975-2955 surname: Kouimtsidis fullname: Kouimtsidis, Christos organization: General Secretariat of Prime Minister, Ministry of Health, Athens, Greece – sequence: 18 givenname: Serenella orcidid: 0000-0003-0740-7893 surname: Tolomeo fullname: Tolomeo, Serenella organization: Department of Psychology, National University of Singapore (NUS), Singapore – sequence: 19 givenname: Seyed Ramin orcidid: 0000-0003-1673-6154 surname: Radfar fullname: Radfar, Seyed Ramin organization: Integrated Substance Abuse Programs, University of California, Los Angeles, California, USA – sequence: 20 givenname: Emran Mohammad orcidid: 0000-0001-9640-981X surname: Razaghi fullname: Razaghi, Emran Mohammad organization: Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32855772$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks9u1DAQxiNUREvpA3BBlrhwyRL_SxwOSKsttCsVdUUp4hY59rjrKrFTO1lpX45nw7tbEOXAyeNvfvN5NJ6X2ZHzDrLsNS5mlPBavG-Vm2E8U35jNa5n-Fl2QggRecUYOUpxUYgck_LHcXYWo20LxiqKCacvsmNKBOdVRU6yn4vr78vzHNdIOo1upjaO0ilAtxHQuY0-aAjxA_oKyvc9OC1H611Eo0cSLXw_BFiDi3YD6BJkN66VDJDoOCQKZmju0NKNENy-TnboxisL4xZ5g-ZaW7WT0RdIkXWAVkEmJT2_a2blO6u2h3qII7oIfhqSGu2-aCUHCK-y50Z2Ec4ez9Ps9vOnb4vL_Or6YrmYX-WaCjHmNa1azVugYDjGxhiM0zQM5rUpGYAsa12YQgioWoUNblOWKq2LdK-YooqeZsuDr_byvhmC7WXYNl7aZi_4cNfIkDrvoCkrIykITuuCMprMSi5FKymtiWAMePL6ePAaprYHrcCNQXZPTJ9mnF03d37TVLQUuKDJ4N2jQfAPUxpN09uooOukAz_FhjAqyqrmVCT07T_ovZ_Sb3SJ2hEMC1z_l2Ipn7alxIl683fffxr-vUz0FzvP0kU |
| ContentType | Journal Article |
| Copyright | Copyright© 2020 Iranian Neuroscience Society. Copyright Negah Scientific Publisher Mar/Apr 2020 Copyright Negah Scientific Publisher 2020 Copyright© 2020 Iranian Neuroscience Society 2020 |
| Copyright_xml | – notice: Copyright© 2020 Iranian Neuroscience Society. – notice: Copyright Negah Scientific Publisher Mar/Apr 2020 – notice: Copyright Negah Scientific Publisher 2020 – notice: Copyright© 2020 Iranian Neuroscience Society 2020 |
| DBID | NPM 8FE 8FH AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M7P PHGZM PHGZT PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.32598/bcn.11.covid19.1 |
| DatabaseName | PubMed ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection (subscription) ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | PubMed ProQuest Central Student ProQuest Biological Science Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed ProQuest Central Student ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 2228-7442 |
| EndPage | 150 |
| ExternalDocumentID | oai_doaj_org_article_67fa3e85390343f1b65a8ba3392844e5 PMC7368103 32855772 |
| Genre | Journal Article |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS M~E NPM --- 5VS 8FE 8FH ABDBF ABIVO ACPRK ACUHS ADBBV AFKRA AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI CCPQU DIK DWQXO EBD EOJEC GNUQQ GROUPED_DOAJ HCIFZ HYE KQ8 LK8 M48 M7P OBODZ OK1 PGMZT PHGZM PHGZT PKEHL PQEST PQGLB PQQKQ PQUKI PRINS RPM 7X8 5PM AFFHD |
| ID | FETCH-LOGICAL-d388t-937bd5be3ef511fff11447f159f64eea69d0f088e7bc1f1b1443cdd0e7b74c3c3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 88 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000548578800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2008-126X |
| IngestDate | Fri Oct 03 12:27:48 EDT 2025 Tue Nov 04 01:54:43 EST 2025 Fri Jul 11 15:10:55 EDT 2025 Fri Jul 25 11:59:13 EDT 2025 Fri Jul 25 11:58:50 EDT 2025 Thu Jan 02 22:45:03 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Policy Substance use disorder Coronavirus Harm reduction Pandemic Methadone Coronavirus Disease 2019 (COVID-19) Addiction medicine Public health Opioid substitution therapy |
| Language | English |
| License | Copyright© 2020 Iranian Neuroscience Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-d388t-937bd5be3ef511fff11447f159f64eea69d0f088e7bc1f1b1443cdd0e7b74c3c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-1673-6154 0000-0002-5445-8290 0000-0002-8784-522X 0000-0001-6492-0429 0000-0002-4175-0137 0000-0002-7668-4280 0000-0001-9640-981X 0000-0002-3303-558X 0000-0002-8932-5420 0000-0002-0876-6559 0000-0002-7234-3710 0000-0001-6902-8798 0000-0001-8697-6183 0000-0002-2421-4201 0000-0002-4987-6818 0000-0001-9975-2955 0000-0002-5388-7376 0000-0003-4871-2552 0000-0002-6877-6169 0000-0003-0740-7893 |
| OpenAccessLink | https://doaj.org/article/67fa3e85390343f1b65a8ba3392844e5 |
| PMID | 32855772 |
| PQID | 2419328561 |
| PQPubID | 2046373 |
| PageCount | 18 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_67fa3e85390343f1b65a8ba3392844e5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7368103 proquest_miscellaneous_2438679538 proquest_journals_2795341819 proquest_journals_2419328561 pubmed_primary_32855772 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-03-01 |
| PublicationDateYYYYMMDD | 2020-03-01 |
| PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Iran |
| PublicationPlace_xml | – name: Iran – name: Tehran |
| PublicationTitle | Basic and clinical neuroscience |
| PublicationTitleAlternate | Basic Clin Neurosci |
| PublicationYear | 2020 |
| Publisher | Negah Scientific Publisher Iranian Neuroscience Society Iran University of Medical Sciences |
| Publisher_xml | – name: Negah Scientific Publisher – name: Iranian Neuroscience Society – name: Iran University of Medical Sciences |
| SSID | ssib044731253 ssj0000603440 |
| Score | 2.4499853 |
| SecondaryResourceType | review_article |
| Snippet | Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who... Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who... Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who... |
| SourceID | doaj pubmedcentral proquest pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 133 |
| SubjectTerms | addiction medicine Addictions Addictive behaviors Behavior Comorbidity coronavirus coronavirus disease 2019 (covid-19) Coronaviruses COVID-19 Disease prevention Disease transmission Drug abuse Drug prevention Drug use Harm reduction Health care Health services Homeless people Infectious diseases Lung diseases Medicine methadone Narcotics opioid substitution therapy pandemic Pandemics policy Psychiatry public health Research centers s Paper Society Stigma Substance abuse treatment Substance use Substance use disorder Tuberculosis |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagIMSFdyFQ0CBxgEPaZO3ECRe0FKpWomUlaLW3yE-6hyZLkvYf8r8YO07EoooLx8SJYyvj8TcPf0PIm9TmVMmMxsrKMma8SGJBLY1LkxVKpDa1no7h7As_OSmWy3IRHG5dSKscdaJX1LpRzke-N-NlhhoXN7AP65-xqxrloquhhMZNcsuxJFCfurcY5YkxTnH_ppPPJckdwZ1zu_iofzrLl0Ogk6IRUOxJVaMGwa9erXRa7qaBxv867Pl3CuUfe9LB_f-dzQNyL6BRmA_i85DcMPUjcuc4xNsfk1_7X8-OPsVpCaLW4JRM76QETjsDI29n9x6cDXtxYUJ9pg76BgQ4TdOa8yFBHg6nPDN82qflml2Y17DhkYSQQwqNhbnWK3_mAsbhwNujb_Pjd7AIB7v8mAZe46EbnD54XxreHVLRYCHWpn1CTg8-f98_jEPhh1jTouhjhExSZ9JQYxEPWmvRaGPcIvKyOTNG5KVOLKpHw6VCcZLYSpXWCV5zpqii22SrbmrzjAACWjTYklyZxDKV5oLRmUSTVnLjKlywiHx0_7haD9welWPb9jea9kcVFm-VcyuoQWBT4hsUP5hnopCCIrYsGDNZRHbGv1wFFdBVCI0QGxeIT69vniQgIq-nZlzbLmAjatNcui6o40PEPSkiTwd5mwbqus7QNIoI35DEjZlsttSrc88fzqkjoaPP_z2sF-TuzPkWfL7dDtnq20vzktxWV_2qa1_5hfYb8TMykQ priority: 102 providerName: ProQuest |
| Title | COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32855772 https://www.proquest.com/docview/2419328561 https://www.proquest.com/docview/2795341819 https://www.proquest.com/docview/2438679538 https://pubmed.ncbi.nlm.nih.gov/PMC7368103 https://doaj.org/article/67fa3e85390343f1b65a8ba3392844e5 |
| Volume | 11 |
| WOSCitedRecordID | wos000548578800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2228-7442 dateEnd: 20221231 omitProxy: false ssIdentifier: ssj0000603440 issn: 2008-126X databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2228-7442 dateEnd: 99991231 omitProxy: false ssIdentifier: ssib044731253 issn: 2008-126X databaseCode: M~E dateStart: 20090101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2228-7442 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000603440 issn: 2008-126X databaseCode: M7P dateStart: 20091001 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2228-7442 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000603440 issn: 2008-126X databaseCode: BENPR dateStart: 20091001 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagIIRUISivQFkNEgc4pE1qJ3a4bctWVKJLBLTaW2Q7trqHZqvdtMf-O_4X48eudlElLlwiJY4sP8aebx7-TMiH3JZUq4Km2qoqZVxkqaSWppUphJa5za2nYzj_xsdjMZlU9dpVXy4nLNADh4HbL7mV1KBSqTLKqM1VWUihJEW9Lhgznr0UUc-aMYWSxBinqLnpytuSlY7azjlcfLw_PygnIcRJEf6LfaU73Dtwjm-mbV7t5ZHA_y7U-Xfy5Jo2On5KnkQYCcPQ_Gfknul2yKPTGCjfIdvBHQfhlNFz8vvo-_nJlzSvQHYtuN2id9MNZwsDSwLOxWdwxujlpYkXLS2gn4EEt2XMzUXIdI81uoQx_Nvn15o9GHaw4VqEmAwKMwvDtp36wxOwbB58PPk5PP0EdTyh5dsUCIpDNTgS4J1i-DXklEEtr8z8BTk7Hv06-prGGxzSlgrRp4h9VFsoQ41FYGetReuLcYsQypbMGFlWbWZxnzNcaZQLhaVUt22G75xpqulLstXNOvOaACJTtLyyUpvMMp2XktEDhbap4sZdVcEScuimrLkKJB2No832H1CYmihMzb-EKSG7ywlv4lpeNIhxEOQKBJp3F_OqQCiAyCoh71fFuEhd5EV2ZnbtqqCO2BCVS0JeBfFZNdRVXaCNkxC-IVgbPdks6aYXngicU8cmR9_8j66_JY-dHyx4l3bJVj-_Nu_IQ33TTxfzAbnPJ2JAHhyOxvWPgV9rA5cmW7vn7egPLIItDQ |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VgoALb4qhwCCBRA9uba-fSAiFlipRkxCJtsrNrNe7bQ61Q5wW8af4F_wvZtcPEVRx64Gjvc54vJmZ_WZ2dgbgtatCJrKA2UJlie1HsWNzppidyCAW3FWuMuUYjofReBxPp8lkDX62Z2F0WmVrE42hzkuhY-Q7XpQEZHFpAfsw_2brrlF6d7VtoVGLxYH88Z1ctur9YI_-3zeet__pcLdvN10F7JzF8dKm9TjLg0wyqQhsKKXII_AjRcu6Cn0peZjkjiLdk1EmiNeMRpnIc4euI18wwYjuNbhOMMKLTargpJVfIsMIL7AuxuOEuqCeDvOYLAPXC6f1xiojpyPeyURBFou-8mKWu8m227QNuAzr_p2y-ccauH_3f5u9e3CnQdvYq9XjPqzJ4gHcHDX5BA_h1-7n48Ge7SbIixy1EV1qLcCjSmJbl7R6h9pHPzuTTf-pCpclctSWdCFP6wMA2O_y6Ohpk3Yst7FX4ErEFZscWSwV9vJ8Zs6UYMsOvh186Y22cNIcXDM81XWbazI03WhihXS3TrXDCZ_LxSM4upJJfAzrRVnIJ4AE2MkhdUIhHeULN-Q-8zJy2bNI6g4evgUftUyl87p2SaqriZsb5eIkbYxTGkaKM0nALaFfMHphGPA444ywc-z7MrBgs5WqtDFxVUrQj7B_TPj78uFO4ix41Q2T7dIbUryQ5bkmwXS9R1pzLdio5btjVJMOyPWzIFqR_JUvWR0pZqemPnrEdJE99vTfbL2EW_3D0TAdDsYHz-C2p-MoJrdwE9aXi3P5HG6Ii-WsWrwwSo7w9ar14jeBlJGY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID-19+and+Substance+Use+Disorders%3A+Recommendations+to+a+Comprehensive+Healthcare+Response.+An+International+Society+of+Addiction+Medicine+%28ISAM%29+Practice+and+Policy+Interest+Group+Position+Paper&rft.jtitle=Basic+and+clinical+neuroscience&rft.au=Ali+Farhoudian&rft.au=Alexander+Baldacchino&rft.au=Nicolas+Clark&rft.au=Gilberto+Gerra&rft.date=2020-03-01&rft.pub=Iran+University+of+Medical+Sciences&rft.issn=2008-126X&rft.eissn=2228-7442&rft.volume=11&rft.issue=2&rft.spage=133&rft.epage=146&rft_id=info:doi/10.32598%2Fbcn.11.covid19.1&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_67fa3e85390343f1b65a8ba3392844e5 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2008-126X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2008-126X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2008-126X&client=summon |